Literature DB >> 6815870

Experimental fecal transmission of human cryptosporidia to pigs, and attempted treatment with an ornithine decarboxylase inhibitor.

H W Moon, A Schwartz, M J Welch, P P McCann, P L Runnels.   

Abstract

Fecal material collected from an immunologically deficient man with persistent cryptosporidia infection was stored in potassium dichromate for two weeks and then fed (inoculated) to newborn pigs. The six inoculated newborn pigs shed the organism in their feces starting four to five days afer inoculation and continuing for as long as 22 days after inoculation. Pigs which were killed and necropsied while shedding had cryptosporidia infection of ileum, cecum, and colon. Infected pigs had atrophied ileal villi and flattened irregular cecal and colonic epithelium. Uninoculated littermate controls remained free to the infection and had histologically normal intestinal tracts at necropsy. Treatment of three of the six inoculated pigs with the ornithine decarboxylase inhibitor, DL-alpha-difluoromethylornithine, orally for ten days had no apparent effect on the infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815870     DOI: 10.1177/030098588201900615

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  14 in total

Review 1.  Cryptosporidium spp. and cryptosporidiosis.

Authors:  R Fayer; B L Ungar
Journal:  Microbiol Rev       Date:  1986-12

Review 2.  Cryptosporidiosis in animals and humans.

Authors:  S Tzipori
Journal:  Microbiol Rev       Date:  1983-03

3.  Occurrence of Cryptosporidium suis and Cryptosporidium scrofarum on commercial swine farms in the Czech Republic and its associations with age and husbandry practices.

Authors:  Karel Němejc; Bohumil Sak; Dana Květoňová; Naděžda Kernerová; Michael Rost; Vitaliano A Cama; Martin Kváč
Journal:  Parasitol Res       Date:  2012-12-28       Impact factor: 2.289

4.  Assessment of chitosan nanoparticles in improving the efficacy of nitazoxanide on cryptosporidiosis in immunosuppressed and immunocompetent murine models.

Authors:  Howayda Said Fouad Moawad; Mohamed Hegab Abd El-Hady Hegab; Maha Saber Reda Badawey; Shaimaa Elsayed Ashoush; Shereen Mahmoud Ibrahim; Amira Abd El-Lateef Saleh Ali
Journal:  J Parasit Dis       Date:  2021-01-06

Review 5.  Cryptosporidiosis.

Authors:  W L Current; L S Garcia
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

6.  Infectivity of Cryptosporidium parvum genotype I in conventionally reared piglets and lambs.

Authors:  M Ebeid; A Mathis; A Pospischil; P Deplazes
Journal:  Parasitol Res       Date:  2003-03-12       Impact factor: 2.289

Review 7.  Cryptosporidium species a "new" human pathogen.

Authors:  D P Casemore; R L Sands; A Curry
Journal:  J Clin Pathol       Date:  1985-12       Impact factor: 3.411

8.  An intestinal xenograft model for Cryptosporidium parvum infection.

Authors:  J D Thulin; M S Kuhlenschmidt; M D Rolsma; W L Current; H B Gelberg
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

Review 9.  Cryptosporidiosis in humans: review of recent epidemiologic studies.

Authors:  T R Navin
Journal:  Eur J Epidemiol       Date:  1985-06       Impact factor: 8.082

10.  Rat model for human cryptosporidiosis.

Authors:  P Brasseur; D Lemeteil; J J Ballet
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.